Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 1
2016 3
2017 3
2018 7
2019 10
2020 12
2021 6
2022 8
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Deferiprone in Parkinson's Disease.
Devos D, Labreuche J, Rascol O, Corvol JC, Duhamel A, Guyon Delannoy P, Poewe W, Compta Y, Pavese N, Růžička E, Dušek P, Post B, Bloem BR, Berg D, Maetzler W, Otto M, Habert MO, Lehericy S, Ferreira J, Dodel R, Tranchant C, Eusebio A, Thobois S, Marques AR, Meissner WG, Ory-Magne F, Walter U, de Bie RMA, Gago M, Vilas D, Kulisevsky J, Januario C, Coelho MVS, Behnke S, Worth P, Seppi K, Ouk T, Potey C, Leclercq C, Viard R, Kuchcinski G, Lopes R, Pruvo JP, Pigny P, Garçon G, Simonin O, Carpentier J, Rolland AS, Nyholm D, Scherfler C, Mangin JF, Chupin M, Bordet R, Dexter DT, Fradette C, Spino M, Tricta F, Ayton S, Bush AI, Devedjian JC, Duce JA, Cabantchik I, Defebvre L, Deplanque D, Moreau C; FAIRPARK-II Study Group. Devos D, et al. N Engl J Med. 2022 Dec 1;387(22):2045-2055. doi: 10.1056/NEJMoa2209254. N Engl J Med. 2022. PMID: 36449420 Clinical Trial.
A randomized clinical trial of candesartan for cognitive impairment in Parkinson's disease.
Kulisevsky J, Martínez-Horta S, Campolongo A, Pascual-Sedano B, Marín-Lahoz J, Bejr-Kasem H, Labandeira-Garcia JL, Lanciego JL, Puig-Davi A, Horta-Barba A, Pagonabarraga J, Rodríguez-Antigüedad J. Kulisevsky J, et al. Among authors: marin lahoz j. Parkinsonism Relat Disord. 2023 May;110:105367. doi: 10.1016/j.parkreldis.2023.105367. Epub 2023 Mar 21. Parkinsonism Relat Disord. 2023. PMID: 36963339 Clinical Trial. No abstract available.
Essential Tremor: Update of Therapeutic Strategies.
Gironell A, Marín-Lahoz J, Póveda S. Gironell A, et al. Among authors: marin lahoz j. Med Clin (Barc). 2024 Mar 28:S0025-7753(24)00030-7. doi: 10.1016/j.medcli.2023.12.013. Online ahead of print. Med Clin (Barc). 2024. PMID: 38553256 Review. English, Spanish.
Serosurveys and convalescent plasma in COVID-19.
Pérez-Cameo C, Marín-Lahoz J. Pérez-Cameo C, et al. Among authors: marin lahoz j. EClinicalMedicine. 2020 May 1;23:100370. doi: 10.1016/j.eclinm.2020.100370. eCollection 2020 Jun. EClinicalMedicine. 2020. PMID: 32632410 Free PMC article. No abstract available.
Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy.
Pagonabarraga J, Horta-Barba A, Busteed L, Bejr-Kasem H, Illán-Gala I, Aracil-Bolaños I, Marín-Lahoz J, Pascual-Sedano B, Pérez J, Campolongo A, Izquierdo C, Martinez-Horta S, Sampedro F, Kulisevsky J. Pagonabarraga J, et al. Among authors: marin lahoz j. Parkinsonism Relat Disord. 2021 Apr;85:63-68. doi: 10.1016/j.parkreldis.2021.03.002. Epub 2021 Mar 12. Parkinsonism Relat Disord. 2021. PMID: 33744691
49 results